32
Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm reduction Model

Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

Embed Size (px)

Citation preview

Page 1: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

Panel:“Medical abortion pills:  how and where do women get them.”

Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias -

Uruguay

Risk and Harm reduction Model

Page 2: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

• Population: 3.3 million

• Maternal Mortality: 23 / 100.000 live births

• Abortion penalized by law since 1938.

Exceptions: • Preserve life of the woman• Rape• Extreme poverty

• Unsafe Abortion was the leading cause of maternal mortality in 2001.

04/21/23

Uruguay

Page 3: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

In 2001, an NGO, Iniciativas Sanitarias (IS), developed a

program to decrease maternal morbidity and mortality from unsafe

abortion and the incidence of unsafe abortion

04/21/23

This program is part of the Sexual & Reproductive

Health Lawsince 2008

Iniciativas Sanitarias – Health Initiatives

Page 4: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

ICPD Paragraph 8.25 and ICPD+5 Paragraph 63i.

• “Women who have unwanted pregnancies should have ready access to reliable information and compassionate counselling”

Our Model follows this important recommendation.

Page 5: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

• Risk and Harm Reduction Strategy– Philosophical education strategy without moral opinion about risk

behaviors (Unsafe abortion)

• Professional Values – medical and health care team values.– Vocation – Discipline – Competence – Commitment

• Bioethics Approach– Respect and promote autonomy– Beneficence – Non maleficence – Justice

• Human Rights approach– Right to Health care assistance– Right to information of scientific progress

• Legal Issues and Local Context– Professional Secrecy - Confidentiality

The framework of the model emphasizes

Page 6: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

1- TO DIMINISH MATERNAL MORBIDITY AND MORTALITY

2- TO DECREASE THE NEED TO HAVE AN ABORTION, AND THUS, THE OVERALL ABORTION RATE

1- THE OBJECTIVE

Page 7: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

ABORTIONABORTION

ILLEGALBEFOREBEFORE AFTERAFTER

THE NEW APPROACH OF “Iniciativas Sanitarias” PROGRAM

04/21/23

Page 8: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

• We speak with the woman, face to face, in a horizontal relationship, taking our time to listen to her instead of censoring her, trying to clarify the reason between the two of us: why she thinks she needs an abortion, and what she really feels, deep in her heart.

• It is necessary to align the “thinking and the feeling”, to avoid women feeling guilty or depressed later.

• We allow them some time to reflect, and decide with freedom.

• This is reinforced with a multidisciplinary consultation with the gynecologist or the midwife, (or either of them) with the psychologist.

BEFOREBEFORE

Page 9: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

• Carrying out a situation diagnosis• Evaluating risk and protection factors• Assessing decision level of the users• Carrying out therapeutic interventions• Identifying the indicators pointing to possible

post-abortion mental health increased damages.• Referring the patient, or carrying out a follow up,

when necessary.

04/21/23

Ob-gyn or Midwife + psychologistAppointment

Page 10: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

ABORTIONABORTION

ILLEGAL

DENIED

BEFOREBEFORE1- Counseling regarding alternatives to abortion

2- Information about abortion methods and their risks: empowerment. (including Misoprostol)

3- Epidemiological analysis

AFTERAFTERPOST-ABORTION CARE

1- Damage Prevention

2- Integral rehabilitation

3- Future contraception(Diminishing the abortion rate)

THE GUIDELINES

04/21/23

Page 11: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

NUMER OF USERS ASSISTED UNDER THE

MODEL: 3215

PERIOD March/2004 – July/2009 PERIOD March/2004 – July/2009

METHODOLOGY

IMPLEMENTATION OF HEALTH INITIATIVES RISK-REDUCTION MODEL IN IMPLEMENTATION OF HEALTH INITIATIVES RISK-REDUCTION MODEL IN THE MAIN WOMEN THIRD LEVEL HEALTH CENTER OF URUGUAYTHE MAIN WOMEN THIRD LEVEL HEALTH CENTER OF URUGUAY

04/21/23

Project supported by:

•F.I.G.O•IPAS•SAAF•IPPF•OMS•UNFPA

Page 12: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

METHODOLOGY

Data was collected using a pre-designed form for the “before-abortion” and “after-abortion” visit, filled by the

professionals and identified with a number

IMPLEMENTATION OF HEALTH INITIATIVES RISK-REDUCTION MODEL

04/21/23

PEREIRA ROSSELL HOSPITAL: MAIN WOMENTHIRD LEVEL HEALTH CENTER OF URUGUAY

Page 13: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

Age distribution

04/21/23

0%

10%

20%

30%

40%

50%

60%

70%

menor de 15 16 a 19 años 20 a 34 años 35 o mas sin dato Less than 15 16 to 19 20 to 34 more than 35 No data

Page 14: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

84,9 % before 13 weeks

“Gestational Age” in patients

who required our service.

Page 15: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

CONTRACEPTION AND CONTRACEPTION AND UNWANTED PREGNANCYUNWANTED PREGNANCY

““BEFORE” VISITS (n: 2206)BEFORE” VISITS (n: 2206)

04/21/23

Page 16: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

REASON N %

INTERFERENCE WITH HER LIFE PROJECT

851 38,6%

ECONOMICS PROBLEMS 873 39,6%

NO PARTNER 272 12,3%

SEXUAL VIOLENCE 23 1,0%

TOO MANY CHILDREN 167 7,6%

OTHERS 243 11,0%

Main reasons given when looking for an abortion

04/21/23

Page 17: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

0%

5%

10%

15%

20%

25%

30%

35%

Acceso Salud Falla No tiene Muerte

ADOLESC.

ADULTS

04/21/23

The main fears that women express PRE-ABORTION

Accessto misoprostol Health Failure of misoprostol No Fears Death

Page 18: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

RESULTSRESULTSIN RELATION WITH IN RELATION WITH

THE USE OF THE USE OF MISOPROSTOL MISOPROSTOL

Page 19: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

IIHome use of misoprostol to interrupt

pregnancy

Use of misoprostol in the sample analysed. Use of misoprostol in the sample analysed.

Method used N %

Misoprostol 448 89,6Misoprostol +

LEC3 0,6

Total misoprostol

451 90,2

Other 4 0,8Total 455 91

Page 20: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

IIHome use of misoprostol to interrupt

pregnancy

Self-administration of misoprostol

Route of administratio

nN %

Muccal mucosa 51 11,3Oral 11 2,4

Vaginal 325 72,1Combined 60 13,3

USE OF MISOPROSTOL 451

Page 21: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

IIHome use of misoprostol to interrupt

pregnancy

Misoprostol dose used

Dose Used (mcg)

N %

400 26 5,8600 12 2,7800 367 81,4

900-1500 14 3,11.600 10 2,2

> 1600 7 1,6

USE OF MISOPROSTOL 451

81,4 % 1 or 2 doses

Page 22: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

II Home use of misoprostol to interrupt

pregnancy

Time between self-administration of misoprostol and expulsion.

Time use/expulsion N %

menos de 6 horas 162 35,9

6 to 11 hours 139 30,8

12 to 23 hours 22 4,9

66,7 % under 12 hours

USE OF MISOPROSTOL 451

Page 23: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

IIHome use of misoprostol to interrupt

pregnancy

Post-use Complications of misoprostol

Complications N %

Other mild 12 2,4

Mild infectious 7 1,6

Milb bleeding leves 10 2,0

NO COMPLICATIONS

423 84,6

USE DE MISOPROSTOL 451

84.6 WITHOUT COMPLICATIONS

Page 24: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

• Most women come to us after having decided to undergo an abortion

• Most common reasons for abortion: life PROJECT and economic problems

• 10% of women did not end up with illegal abortion

• 55% did engage in abortion but under safer conditions

• 21% continued with pregnancy

• Misoprostol (self-administered and in the context of the health program) is very effective and safe.

CONCLUSIONS AND PERSPECTIVES

Page 25: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

• In the black market.

• Some women help others when they have extra pills.

• In friendly pharmacies.

• Through internet.

• Using cell phones in public restrooms at shopping malls.

• Very high prices.

HOW AND WHERE

Page 26: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

• At the professional associations level, we are working for the Ministry of Public Health to enforce Act 18426 of Sexual and Reproductive Health Rights, and for it to regulate the ambulatory use of misoprostol to treat incomplete abortions.

• To prescribe or not to prescribe?

• Professionals as guarantors of sexual and reproductive rights

HOW AND WHERE

Page 27: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

CONCLUSIONS AND PERSPECTIVES

• Since 2004, Uruguay has been a country that, in spite of a restrictive abortion law, provides comprehensive health care services to women with unwanted pregnancies

• Maternal mortality has declined in recent years in hospital and throughout the country

• Patients visit the Service in earlier stages of pregnancy

04/21/23

Page 28: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

5- PERSPECTIVES AND CHALLENGES

• EXPAND THIS SUCCESSFUL MODEL IN URUGUAY

• SHARE THE MODEL IN LATIN AMERICA AND BEYOND

• INCREASE PROFESSIONAL COMMITMENT WITH SEXUAL AND REPRODUCTIVE RIGHTS

• TRANFORM THE PROFESSIONAL – PATIENT RELATIONSHIP TO:– EMPOWER WOMEN – DEVELOP PROFESSIONAL VALUES

Page 30: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

GRAFICO 5- MORTALIDAD MATERNA EN URUGUAY Y EN EL CHPR (2000- 2007)

0

20

40

60

80

100

120

2000 2001 2002 2003 2004 2005 2006 2007 2008

AÑOS

TA

SA

M.M

. / 1

00.0

00 R

NV

URUGUAY

CHPR

Lineal (CHPR)

Lineal (URUGUAY)

GRAFICO 5- MORTALIDAD MATERNA EN URUGUAY Y EN EL CHPR (2000- 2007)

0

20

40

60

80

100

120

2000 2001 2002 2003 2004 2005 2006 2007 2008

AÑOS

TA

SA

M.M

. / 1

00.0

00 R

NV

URUGUAY

CHPR

Lineal (CHPR)

Lineal (URUGUAY)

Page 31: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

GRAFICO 6- MORTALIDAD MATERNA POR APCR URUGUAY Y CHPR

0

10

20

30

40

50

60

70

80

2000 2001 2002 2003 2004 2005 2006 2007 2008

AÑOS

FR

EC

UE

NC

IA R

EL

AT

IVA

DE

M.M

. PO

R A

.P.C

.R.

URUGUAY

CHPR

Lineal (URUGUAY)

Lineal (CHPR)

GRAFICO 6- MORTALIDAD MATERNA POR APCR URUGUAY Y CHPR

0

10

20

30

40

50

60

70

80

2000 2001 2002 2003 2004 2005 2006 2007 2008

AÑOS

FR

EC

UE

NC

IA R

EL

AT

IVA

DE

M.M

. PO

R A

.P.C

.R.

URUGUAY

CHPR

Lineal (URUGUAY)

Lineal (CHPR)

Page 32: Panel:“Medical abortion pills: how and where do women get them.” Midwife Ana Labandera Monteblanco Director Iniciativas Sanitarias - Uruguay Risk and Harm

INGRESO A C.T.I. POR COMPLICACIONES DEL ABORTO INSEGURO

0

2

4

6

8

10

12

14

16

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

AÑO

FR

EC

. RE

LA

TIV

A D

E IN

GR

ES

O A

C.T

.I.

C.H.P.R.INGRESO A C.T.I.PORCOMPLICACIONDEL A.P.C.R.

Lineal (C.H.P.R.INGRESO A C.T.I.PORCOMPLICACIONDEL A.P.C.R.)

ADMITED TO THE ICU DUE TO UNSAFE ABORTION COMPLICATIONS